COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA
PURPOSE:To obtain the subject multiple drug-resistant and safe composition, comprising carbamoyl-beta-D-ribofuranosyl-imidazolium-oleate as an active ingredient, capable of rapidly improving symptoms and reducing the weight of a steroidal agent used in combination and having low toxicity. CONSTITUTI...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MORIMOTO IPPEI |
| description | PURPOSE:To obtain the subject multiple drug-resistant and safe composition, comprising carbamoyl-beta-D-ribofuranosyl-imidazolium-oleate as an active ingredient, capable of rapidly improving symptoms and reducing the weight of a steroidal agent used in combination and having low toxicity. CONSTITUTION:This composition comprises 4-carbamoyl-1-beta-D- ribofuranosylimidazolium-5-oleate (generic name: mizoribine) as an active ingredient. A commercially available pharmaceutical preparation of the mizoribine for oral administration is preferably simply used as the composition. The composition is preferably administered in a daily dose of 100-300mg at a time in 2-3 divided portions to an adult patient weighing 50-60kg by using a 25-mg or a 50-mg tablet of the pharmaceutical preparation of the mizoribine for the oral administration. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH07215880A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH07215880A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH07215880A3</originalsourceid><addsrcrecordid>eNrjZDBx9vcN8A_2DPH091Nw8w9SCAlydQzx9HNXcAwN8ff09Q31c1XwcPX194kM8XRWcPRz9fV05GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHgbmRoamFhYGjsbEqAEA9xAn8Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA</title><source>esp@cenet</source><creator>MORIMOTO IPPEI</creator><creatorcontrib>MORIMOTO IPPEI</creatorcontrib><description>PURPOSE:To obtain the subject multiple drug-resistant and safe composition, comprising carbamoyl-beta-D-ribofuranosyl-imidazolium-oleate as an active ingredient, capable of rapidly improving symptoms and reducing the weight of a steroidal agent used in combination and having low toxicity. CONSTITUTION:This composition comprises 4-carbamoyl-1-beta-D- ribofuranosylimidazolium-5-oleate (generic name: mizoribine) as an active ingredient. A commercially available pharmaceutical preparation of the mizoribine for oral administration is preferably simply used as the composition. The composition is preferably administered in a daily dose of 100-300mg at a time in 2-3 divided portions to an adult patient weighing 50-60kg by using a 25-mg or a 50-mg tablet of the pharmaceutical preparation of the mizoribine for the oral administration.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SUGARS</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19950815&DB=EPODOC&CC=JP&NR=H07215880A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19950815&DB=EPODOC&CC=JP&NR=H07215880A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MORIMOTO IPPEI</creatorcontrib><title>COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA</title><description>PURPOSE:To obtain the subject multiple drug-resistant and safe composition, comprising carbamoyl-beta-D-ribofuranosyl-imidazolium-oleate as an active ingredient, capable of rapidly improving symptoms and reducing the weight of a steroidal agent used in combination and having low toxicity. CONSTITUTION:This composition comprises 4-carbamoyl-1-beta-D- ribofuranosylimidazolium-5-oleate (generic name: mizoribine) as an active ingredient. A commercially available pharmaceutical preparation of the mizoribine for oral administration is preferably simply used as the composition. The composition is preferably administered in a daily dose of 100-300mg at a time in 2-3 divided portions to an adult patient weighing 50-60kg by using a 25-mg or a 50-mg tablet of the pharmaceutical preparation of the mizoribine for the oral administration.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBx9vcN8A_2DPH091Nw8w9SCAlydQzx9HNXcAwN8ff09Q31c1XwcPX194kM8XRWcPRz9fV05GFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHgbmRoamFhYGjsbEqAEA9xAn8Q</recordid><startdate>19950815</startdate><enddate>19950815</enddate><creator>MORIMOTO IPPEI</creator><scope>EVB</scope></search><sort><creationdate>19950815</creationdate><title>COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA</title><author>MORIMOTO IPPEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH07215880A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1995</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>MORIMOTO IPPEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MORIMOTO IPPEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA</title><date>1995-08-15</date><risdate>1995</risdate><abstract>PURPOSE:To obtain the subject multiple drug-resistant and safe composition, comprising carbamoyl-beta-D-ribofuranosyl-imidazolium-oleate as an active ingredient, capable of rapidly improving symptoms and reducing the weight of a steroidal agent used in combination and having low toxicity. CONSTITUTION:This composition comprises 4-carbamoyl-1-beta-D- ribofuranosylimidazolium-5-oleate (generic name: mizoribine) as an active ingredient. A commercially available pharmaceutical preparation of the mizoribine for oral administration is preferably simply used as the composition. The composition is preferably administered in a daily dose of 100-300mg at a time in 2-3 divided portions to an adult patient weighing 50-60kg by using a 25-mg or a 50-mg tablet of the pharmaceutical preparation of the mizoribine for the oral administration.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_JPH07215880A |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS |
| title | COMPOSITION FOR TREATING AUTOIMMUNE HEMOLYTIC ANEMIA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T00%3A27%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MORIMOTO%20IPPEI&rft.date=1995-08-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH07215880A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |